Official Release Repository: CDC | Page 2 of 3

CDC recommends everyone 6 months and older get an updated COVID-19 vaccine. Updated COVID-19 vaccines from Pfizer-BioNTech and Moderna will be available later this week.

CDC Media Release – September 12, 2023

CDC adopts ACIP recommendation for the use of nirsevimab (Beyfortus, Sanofi), a long-acting monoclonal antibody product shown to reduce the risk of both hospitalizations and healthcare visits for RSV in infants by about 80 percent

CDC Media Release – August 3, 2023

CDC posts updated Multiple Vaccines (“Your Child’s First Vaccines”) Vaccine Information Statement

CDC VIS – July 24, 2023

CDC posts new Respiratory Syncytial Virus (RSV) Vaccine Information Statement

CDC VIS – July 24, 2023

CDC adopts 2023-24 ACIP flu vaccination recommendations, to be published later this summer

CDC ACIP – June 29, 2023

CDC recommends RSV vaccine for older adults using shared clinical decision-making

CDC Media Release – June 29, 2023

Updated Hepatitis B Vaccine Information Statement (VIS) posted

CDC VIS – May 12, 2023

Updated Pneumococcal Conjugate Vaccine Information Statement (VIS) posted

CDC VIS – May 5, 2023

CDC simplifies COVID-19 vaccine recommendations, allows older adults and immunocompromised adults to get second dose of the bivalent vaccine. Monovalent (original) COVID-19 mRNA COVID-19 vaccines no longer recommended for use in the United States.

CDC Media Release – April 19, 2023

2023 U.S. Recommended Immunization Schedule for Adults Aged 19 Years or Older

CDC – February 10, 2023

2023 U.S. Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger

CDC – February 10, 2023

CDC expands updated COVID-19 vaccines to include children ages 6 months through 5 years

CDC Media Release – December 9, 2022

Updated Vaccine Information Statement (VIS) for smallpox/monkeypox vaccine (Jynneos) released

CDC VIS – November 14, 2022

CDC allows those 18 years and older option to receive a Novavax monovalent booster instead of an updated (bivalent) Pfizer-BioNTech or Moderna booster if they have completed primary series vaccination but have not previously received a COVID-19 booster.

CDC Media Release – October 19, 2022

CDC recommends expanding the use of updated (bivalent) COVID-19 vaccines (Pfizer-BioNTech for children ages 5 through 11 years, Moderna for children and adolescents ages 6 through 11 years) to children ages 5 through 11 years.

CDC Media Release – October 12, 2022

US joins list of 30 countries that meet WHO criteria for circulating vaccine-derived poliovirus (cVDPV)

CDC Media Release – September 13, 2022

CDC recommends the first updated COVID-19 booster (bivalent booster)

CDC Media Release – September 1, 2022

Updated Vaccine Information Statement (VIS) for smallpox/monkeypox vaccine (Jynneos) released

CDC VIS – August 23, 2022

CDC recommends Novavax COVID-19 vaccine for use in adolescents 12 years through 17 years as a primary series option.

CDC Media Release – August 22, 2022

New Vaccine Information Statement (VIS) posted for Ebola vaccine

CDC VIS – June 30, 2022

CDC endorsed ACIP recommendation of Moderna’s COVID-19 vaccine for those 6 through 17 years of age, in addition to its already recommended use in children 6 months through 5 years and adults 18 years and older

CDC Media Release – June 24, 2022

CDC endorsed the ACIP recommendation that all children 6 months through 5 years of age should receive a Moderna or Pfizer-BioNTech COVID-19 vaccine. All children, including children who have already had COVID-19, should get vaccinated

CDC Media Release – June 18, 2022

Updated Vaccine Information Statement (VIS) for rabies vaccine released

CDC VIS – June 2, 2022

New Vaccine Information Statement (VIS) for smallpox/monkeypox vaccine (Jynneos) released

CDC VIS – June 1, 2022

CDC recommends that children ages 5 through 11 years should receive a booster shot 5 months after their initial Pfizer-BioNTech vaccination series, strengthens its recommendation that those 12 and older who are immunocompromised and those 50 and older should receive a second booster dose at least 4 months after their first

CDC Media Release – May 19, 2022

CDC recommends additional boosters for certain Individuals

CDC Media Release – March 29, 2022

2022 U.S. Recommended Immunization Schedule for Adults Aged 19 Years or Older

CDC – February 18, 2022

2022 U.S. Recommended Immunization Schedules for Children and Adolescents Aged 18 Years or Younger

CDC – February 18, 2022

New Vaccine Information Statement (VIS) for pneumococcal conjugate vaccine (PCV13, PCV15, and PCV20) released.

CDC VIS – February 4, 2022

Updated VIS for recombinant zoster (shingles) vaccine released.

CDC VIS – February 4, 2022

CDC's latest information about Vaccine Information Statements (VIS) currently under development or newly released.

CDC VIS – February 4, 2022

CDC endorses ACIP recommendation to expand eligibility of booster doses to those 12 to 15 years old. CDC recommends that all adolescents age 12 to 17 years old should receive a booster shot 5 months after their initial Pfizer-BioNTech vaccination series.

CDC Media Release – January 5, 2022

CDC recommends Pfizer-BioNTech booster 5 months after completing primary series. CDC recommends moderately or severely immunocompromised 5 to 11 year olds receive an additional primary dose of Pfizer-BioNTech COVID-19 vaccine 28 days after their second shot.

CDC Media Release – January 4, 2022

New Dengue Vaccine Information Statement (VIS) released.

CDC VIS – December 17, 2021

CDC expands booster recommendations to adolescents ages 16 and 17 if at least six months after their initial Pfizer vaccination series.

CDC Media Release – December 9, 2021

CDC recommends everyone 18 years of age and older get a booster shot when they are 6 months after their initial Pfizer or Moderna series or 2 months after their initial J&J vaccine.

CDC Media Release – November 29, 2021

Updated Vaccine Information Statements (VIS) for Hepatitis A, Hepatitis B, and Rotavirus vaccines have been posted. Also, an updated version of the multiple pediatric vaccine VIS, "Your Child's First Vaccines: What You Need to Know"

CDC VIS – October 15, 2021

Updated Vaccine Information Statements (VIS) for DTaP, Hib, HPV, live attenuated influenza, inactivated influenza, MMR, MMRV, MenACWY, MenB, PCV13, Polio, Tdap, Td, and VAR have been posted

CDC VIS – August 6, 2021

CDC and FDA have recommended a pause in the use of the Janssen (Johnson & Johnson) COVID-19 vaccine in the United States out of an abundance of caution.

CDC Media Release – April 23, 2021

CDC and FDA lift recommended pause of use of Johnson & Johnson (Janssen) COVID-19 Vaccine in the U.S. after a review by ACIP. Use of vaccine should resume. EUA fact sheets for Johnson & Johnson (Janssen) COVID-19 Vaccine revised.

CDC Media Release – April 23, 2021

Updated Hepatitis A Vaccine Information Statement released

CDC VIS – July 28, 2020

Updated Vaccine Information Statements for DTaP (diphtheria, tetanus and pertussis), Td (tetanus, diphtheria), Tdap (tetanus, diphtheria, and pertussis), yellow fever, and Multi-Vaccines have been posted

CDC VIS – April 1, 2020

Updated Vaccine Information Statements for adenovirus, anthrax, and rabies vaccines have been posted.

CDC VIS – January 8, 2020

Updated Vaccine Information Statements for zoster/shingles (live), zoster/shingles (recombinant), pneumococcal conjugate (PCV13), pneumococcal polysaccharide (PPSV23), polio, HPV, Hib, rotavirus, cholera, and typhoid have been posted.

CDC VIS – October 30, 2019

Updated Vaccine Information Statements for live attenuated influenza, inactivated influenza, meningococcal ACWY, meningococcal B, MMR, MMRV, varicella, hepatitis B, and Japanese encephalitis have been posted.

CDC VIS – August 15, 2019

Updated Hepatitis B Vaccine Information Statement released

CDC VIS – October 12, 2018

Updated Meningococcal ACWY and DTaP Vaccine Information Statements released

CDC VIS – August 24, 2018

Updated Anthrax Vaccine Information Statement released

CDC VIS – March 21, 2018

Updated Rotavirus Vaccine Information Statement released

CDC VIS – February 23, 2018

Recombinant Zoster (new) and MMR, MMRV, Varicella and Live Zoster (updated) Vaccine Information Statements released

CDC VIS – February 12, 2018

Cholera Vaccine Information Statement released

CDC VIS – July 6, 2017

Updated Td (Tetanus and Diphtheria) Vaccine Information Statement released

CDC VIS – April 11, 2017

Updated HPV (Human Papillomavirus) Vaccine Information Statement released

CDC VIS – December 2, 2016

Serogroup B Meningococcal (MenB) Vaccine Information Statement released

CDC VIS – August 9, 2016

Hepatitis A, Hepatitis B, and Polio Vaccine Information Statements released

CDC VIS – July 20, 2016

ACIP votes to not recommend the use of LAIV (FluMist) during the 2016-2017 influenza season

CDC MMWR – June 22, 2016

Nine states have reported measles cases in 2016

CDC – June 1, 2016

May Is Hepatitis Awareness Month

CDC – May 1, 2016

HPV Gardasil-9 Vaccine Information Statement released

CDC VIS – March 31, 2016

Meningococcal ACWY Vaccines (MenACWY and MPSV4) Vaccine Information Statement released

CDC VIS – March 31, 2016

PCV13 Vaccine Information Statement released (dated 11/5/15)

CDC VIS – November 5, 2015

Multi Pediatric Vaccines Vaccine Information Statement released (dated 11/5/15)

CDC VIS – November 5, 2015

CDC Update: Shortened Interval for Postvaccination Serologic Testing of Infants Born to Hepatitis B-Infected Mothers

CDC MMWR – October 9, 2015

CDC releases new Vaccine Information Statement for serogroup B meningococcal vaccines (MenB)

CDC VIS – August 14, 2015

Vaccine Topics

General Topics

Patient Safety Honor Rolls

Our Affiliated Sites